FATE THERAPEUTICS INC Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2013 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Fate Therapeutics Inc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2013 to Q3 2024.
  • Fate Therapeutics Inc Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $11.8M, a 16.4% increase year-over-year.
  • Fate Therapeutics Inc Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $41.9M, a 21.6% decline year-over-year.
  • Fate Therapeutics Inc annual Share-based Payment Arrangement, Expense for 2023 was $43.5M, a 44.8% decline from 2022.
  • Fate Therapeutics Inc annual Share-based Payment Arrangement, Expense for 2022 was $78.7M, a 44.8% increase from 2021.
  • Fate Therapeutics Inc annual Share-based Payment Arrangement, Expense for 2021 was $54.4M, a 76.8% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $41.9M $11.8M +$1.66M +16.4% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $40.2M $9.63M -$3.27M -25.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $43.5M $11M -$2K -0.02% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $43.5M $9.48M -$9.92M -51.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-26
Q3 2023 $53.4M $10.1M -$9.36M -48.1% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $62.7M $12.9M -$7.65M -37.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $70.4M $11M -$8.35M -43.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $78.7M $19.4M +$4.8M +32.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-26
Q3 2022 $73.9M $19.5M +$5.93M +43.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $68M $20.5M +$7.29M +55% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $60.7M $19.3M +$6.36M +49% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 $54.4M $14.6M +$5.83M +66.6% Oct 1, 2021 Dec 31, 2021 10-K 2023-02-28
Q3 2021 $48.5M $13.5M +$5.7M +72.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $42.8M $13.3M +$6.02M +83.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 $36.8M $13M +$6.06M +87.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $30.8M $8.76M +$4.18M +91.2% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 $26.6M $7.84M +$3.27M +71.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $23.3M $7.24M +$2.85M +65% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 $20.5M $6.91M +$3.05M +78.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 $17.4M $4.58M +$2.8M +157% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-28
Q3 2019 $14.6M $4.57M +$2.93M +179% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $11.7M $4.39M +$2.9M +195% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 $8.78M $3.87M +$2.49M +180% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $6.29M $1.78M +$889K +99.3% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-24
Q3 2018 $5.4M $1.64M +$771K +88.5% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 $4.63M $1.49M +$512K +52.6% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 $4.12M $1.38M +$515K +59.4% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 $3.61M $895K +$77K +9.41% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-02
Q3 2017 $3.53M $871K +$88K +11.2% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-01
Q2 2017 $3.44M $973K +$187K +23.8% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-06
Q1 2017 $3.25M $867K +$70K +8.78% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $3.18M $818K +$338K +70.4% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-05
Q3 2016 $2.85M $783K +$209K +36.4% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-01
Q2 2016 $2.64M $786K +$48K +6.5% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 $2.59M $797K +$189K +31.1% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 $2.4M $480K -$132K -21.6% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-05
Q3 2015 $2.53M $574K +$47K +8.92% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-07
Q2 2015 $2.49M $738K +$314K +74.1% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q1 2015 $2.17M $608K -$263K -30.2% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 $2.43M $612K +$227K +59% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-16
Q3 2014 $2.21M $527K -$455K -46.3% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-03
Q2 2014 $2.66M $424K +$312K +279% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-05
Q1 2014 $2.35M $871K +$796K +1061% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-07
Q4 2013 $1.55M $385K Oct 1, 2013 Dec 31, 2013 10-K 2016-03-03
Q3 2013 $982K Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-12
Q2 2013 $112K Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-12
Q1 2013 $75K Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.